- Home
- NSTS vs BYSI Comparison
NSTS vs BYSI Comparison
Compare NSTS & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- BYSI
- Stock Information
- Founded
- NSTS 1921
- BYSI 2010
- Country
- NSTS United States
- BYSI United States
- Employees
- NSTS N/A
- BYSI N/A
- Industry
- NSTS Savings Institutions
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- BYSI Health Care
- Exchange
- NSTS Nasdaq
- BYSI Nasdaq
- Market Cap
- NSTS 65.8M
- BYSI 72.1M
- IPO Year
- NSTS N/A
- BYSI 2017
- Fundamental
- Price
- NSTS N/A
- BYSI $1.31
- Analyst Decision
- NSTS
- BYSI
- Analyst Count
- NSTS 0
- BYSI 0
- Target Price
- NSTS N/A
- BYSI N/A
- AVG Volume (30 Days)
- NSTS 2.7K
- BYSI 24.5K
- Earning Date
- NSTS 05-12-2025
- BYSI 01-01-0001
- Dividend Yield
- NSTS N/A
- BYSI N/A
- EPS Growth
- NSTS N/A
- BYSI N/A
- EPS
- NSTS N/A
- BYSI N/A
- Revenue
- NSTS $8,931,000.00
- BYSI N/A
- Revenue This Year
- NSTS N/A
- BYSI N/A
- Revenue Next Year
- NSTS N/A
- BYSI N/A
- P/E Ratio
- NSTS N/A
- BYSI N/A
- Revenue Growth
- NSTS 82.49
- BYSI N/A
- 52 Week Low
- NSTS $9.37
- BYSI $0.98
- 52 Week High
- NSTS $13.32
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- NSTS 60.88
- BYSI 44.17
- Support Level
- NSTS $10.80
- BYSI $1.03
- Resistance Level
- NSTS $12.22
- BYSI $1.27
- Average True Range (ATR)
- NSTS 0.26
- BYSI 0.15
- MACD
- NSTS 0.12
- BYSI 0.00
- Stochastic Oscillator
- NSTS 98.45
- BYSI 48.53
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.